Skip to main content
Log in

Therapeutic use of surfactant in neonatal respiratory distress syndrome

Correlation between pulmonary X-ray changes and clinical data

  • Originals
  • Published:
Pediatric Radiology Aims and scope Submit manuscript

Abstract

As part of a multicenter surfactant rescue study, the chest X-rays of 239 preterm and term infants were analyzed. To study the influence of surfactant administration on radiographic appearance, 130 patients with a clinical and radiological diagnosis of typical respiratory distress syndrome were selected, in whom adequate chest x-rays before and within 48 h after treatment were available. Median gestational age was 30 weeks (range 25–38 weeks), median birth weight was 1335 g (range 625–3450). The time of surfactant application ranged between 90 min and 24 h after birth (median 6 h). The most common finding after surfactant administration was uniform (n=47) or disproportionate (n=46) improvement of pulmonary aeration, which showed a significant correlation to posttreatment reduction of oxygen requirement (p<0.001). Asymmetric clearance was more often localized on the right side and usually disappeared within two to five days. Only in 13 patients no change of ventilation was found. Development of interstitial emphysema (n=24, including three patients with pneumothorax) after surfactant treatment was an unfavourable prognostic sign. 54% of these patients (13 of 24) died within the first month of life, compared to 8% (7 of 93) in the group of patients with initial improvement of ventilation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Reynolds MS, Wallander KA (1989) Use of surfactant in the prevention and treatment of neonatal respiratory distress syndrome. Clin Pharm 8:559–576

    PubMed  Google Scholar 

  2. Halliday HL (1989) Clinical experience with exogenous natural surfactant. Dev Pharmacol Ther 13:173–181

    PubMed  Google Scholar 

  3. Horbar JD, Soll RF, Sutherland JM, Kotagal U, Philip AGS, Kessler DL, Little GA, Edwards WH, Vidyasagar D, Raju TNK, Jobe AH, Ikegami M, Mullett MD, Myerberg DZ, McAuliffe TL, Lucey JF (1989) A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. N Engl J Med 320:959–965

    PubMed  Google Scholar 

  4. Morton NS (1989) Pulmonary surfactant: physiology, pharmacology and clinical uses. Br J Hosp Med 42:52–58

    PubMed  Google Scholar 

  5. Robertson B (1988) Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Pediatrics 82:683–691

    PubMed  Google Scholar 

  6. Edwards DK, Hilton SvW, Merrit TA, Hallman M, Mannino F, Boynton BR (1985) Respiratory distress syndrome treated with human surfactant: radiographic findings. Radiology 157:329–334

    PubMed  Google Scholar 

  7. Mortensson W, Noack G, Curstedt T, Herin P, Robertson B (1987) Radiologic observations in severe neonatal respiratory distress syndrome treated with isolated phospholipid fraction of natural surfactant. Acta Radiol 28:389–394

    PubMed  Google Scholar 

  8. Wood BP, Sinkin RA, Kendig JW, Notter RH, Shapiro DL (1987) Exogenous lung surfactant: effect on radiographic appearance in premature infants. Radiology 165:11–13

    PubMed  Google Scholar 

  9. Clarke EA, Siegle RL, Gong AK (1989) Findings on chest radiographs after prophylactic pulmonary surfactant treatment of premature infants. AJR 153:799–802

    PubMed  Google Scholar 

  10. Jorch G (1990) Therapieversager unter Surfactant-Substitution-Multizentrische Studie mit 425 Patienten (Abstract). Monatsschr Kinderheilkd 138:488

    Google Scholar 

  11. Disse B, Gortner L, Weller E, Eberhardt H, Ziegler H (1989) Efficacy and standardisation of SF-RI 1: a preparation from bovine lung surfactant. In: Lachmann B (ed) Surfactant replacement therapy. Springer, Berlin Heidelberg New York, pp 37–41

    Google Scholar 

  12. Jorch G, Rabe H, Garbe M, Michel E, Gortner L (1989) Acute and protracted effects of intratracheal surfactant application on internal carotid blood flow velocity, blood pressure and carbondioxide tension in very low birth weight infants. Eur J Pediatr 148:770–773

    PubMed  Google Scholar 

  13. Giedion A, Haefliger H, Dangel P (1973) Acute pulmonary X-ray changes in hyaline membrane disease treated with artificial ventilation and positive end-expiratory pressure (PEP). Pediatr Radiol 1:145–152

    PubMed  Google Scholar 

  14. Swischuk LE (1977) Bubbles in hyaline membrane disease. Radiology 122:417–426

    PubMed  Google Scholar 

  15. Higgins CB, Rausch J, Friedman WF, Hirschklau MJ, Kirkpatrick SE, Goergen TG, Reinke RT (1977) Patent ductus arteriosus in preterm infants with idiopathic respiratory distress syndrome. Radiology 124:189–195

    PubMed  Google Scholar 

  16. Wesenberg RL, Wax RE, Zachman RD (1972) Varying roentgenographic patterns of patent ductus arteriosus in the newborn. AJR 114:340–349

    Google Scholar 

  17. Tamura M, Kawano T (1989) The effect of reconstituted bovine surfactant on pulmonary mechanics in infants with respiratory distress syndrome. Acta Paediatr Jpn Overseas Ed 31:734–741

    Google Scholar 

  18. Hjalmarson O (1981) Epidemiology and classification of acute, neonatal respiratory disorders. A prospective study. Acta Paediatr Scand 70:773–783

    PubMed  Google Scholar 

  19. Charon A, Taeusch HW, Fitzgibbon C, Smith GB, Treves ST, Phelps DS (1989) Factors associated with surfactant treatment response in infants with severe respiratory distress syndrome. Pediatrics 83:348–354

    PubMed  Google Scholar 

  20. Walti H, Couchard M, Relier JP (1989) Neonatal diagnosis of respiratory distress syndrome. Eur Respir J (Suppl) 3:22s-26s

    Google Scholar 

  21. Reilly BJ (1975) Regional distribution of atelectasis and fluid in the neonate with respiratory distress. Radiol Clin North Am 13: 225–250

    PubMed  Google Scholar 

  22. Swischuk LE (1989) Imaging of the newborn, infant, and young child, 3rd edn. Williams and Wilkins, Baltimore

    Google Scholar 

  23. Gattinoni L, Pesenti A, Bombino M, Baglioni S, Rivolta M, Rossi F, Rossi G, Fumagalli R, Marcolin R, Mascheroni D, Torresin A (1988) Relationships between lung computed tomographic density, gas exchange, and PEEP in acute respiratory failure. Anesthesiology 69:824–832

    PubMed  Google Scholar 

  24. Konishi M, Fujiwara T, Naito T, Takeuchi Y, Ogawa Y, Inukai K, Fujimura M, Nakamura H, Hashimoto T (1988) Surfactant replacement therapy in neonatal respiratory distress syndrome. A multi-centre, randomized clinical trial: comparison of high-versus low-dose of surfactant TA. Eur J Pediatr 147:20–25

    PubMed  Google Scholar 

  25. Jobe A (1989) Protein leaks and surfactant dysfunction in the pathogenesis of respiratory distress syndrome. Eur Respir J (Suppl) 3:27s-32s

    Google Scholar 

  26. Strayer DS, Merrit TA, Hallman M (1989) Surfactant replacement: immunological considerations. Eur Respir J (Suppl) 3:91s-96s

    Google Scholar 

  27. Bevilacqua G, Gaioni L, Parmigiani S (1989) Management of pretern infants receiving surfactant supplementation. Eur Respir J (Suppl) 3:87s-90s

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bick, U., Müller-Leisse, C., Tröger, J. et al. Therapeutic use of surfactant in neonatal respiratory distress syndrome. Pediatr Radiol 22, 169–173 (1992). https://doi.org/10.1007/BF02012487

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02012487

Keywords

Navigation